Future prospects for the MODS assay in multidrug-resistant tuberculosis diagnosis

Future Microbiology

Volumn 2, Issue 2, 2007, Pages 97-101

  Moore, David A J ^a,b  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL OVERGROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BIOSAFETY; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG TREATMENT FAILURE; EDITORIAL; FUNGUS GROWTH; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SERVICE TRAINING; INFECTION CONTROL; INFECTION RISK; LIQUID CULTURE; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; REPRODUCIBILITY OF RESULTS;

EID: 34248676023     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.2.2.97     Document Type: Editorial

References (16)

1. Gandhi NR, Moll A, Sturm AW et al.: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368(9547), 1575-1580 (2006).
2. MMWR: Notice to readers: revised definition of extensively drug-resistant tuberculosis. JAMA 296, 2792 (2006).
3. Emergence of Myobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. Morb. Mortal. Wkly Rep. 55(11), 301-305 (2006).
4. Hart JT. The inverse care law. Lancet 1(7696), 405-412 (1971).
5. Farmer P, Kim JY: Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus". Br. Med. J. 317(7159), 671-674 (1998).
6. Mitnick C, Bayona J, Palacios E et al.: Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N. Engl. J. Med. 348(2), 119-128 (2003).
7. Madison B, Robinson-Dunn B, George I et al.: Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods. J. Clin. Microbiol. 40(11), 3976-3979 (2002).
8. Zhang Y, Permar S, Sun Z: Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J. Med. Microbiol. 51(1), 42-49 (2002).
9. Caviedes L, Lee TS, Gilman RH et al.: Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J. Clin. Microbiol. 38(3), 1203-1208 (2000).
10. Moore DA, Mendoza D, Gilman RH et al.: Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J. Clin. Microbiol. 42(10), 4432-4437 (2004).
11. Franzblau SG, Witzig RS, McLaughlin JC et al.: Rapid, low-technology MIC determination with clinical Myobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36(2), 362-366 (1998).
12. Moore DA, Evans CA, Gilman RH et al.: Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N. Engl. J. Med. 355(15), 1539-1550 (2006).
13. Moore DA, Caviedes L, Gilman RH et al.: Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting. Diagn. Microbiol. Infect. Dis. 56(1), 35-43 (2006).
14. Irfan S, Hasan R, Kanji A, Hassan Q, Azam I: Evaluation of a microcolony detection method and phage assay for rapid detection of Myobacteriun tuberculosis in sputum samples. Southeast Asian J. Trop. Med. Publich Health 37(6), 1187-1195 (2006).
15. Shiferaw G, Woldeamanuel Y, Gebeyehu M et al.: Evaluation of microscopic observation drug susceptibility assay (MODS) for the detection of multidrug-resistant tuberculosis (MDR-TB). J. Clin. Microbiol. DOI: 10.1128/JCM.01949-06 (2007) (Epub ahead of print).
16. Arias M, Mello FCQ, Pavon A et al.: Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin. Infect. Dis. 44(5), 674-680 (2007).